RESUMO
Mice reconstituted with BCR/ABL-infected 5-fluorouracil-treated bone marrow are considered a model system for human chronic myelogenous leukemia, a malignancy that arises in hematopoietic stem cells. These animals develop multiple types of hematopoietic tumors, which could arise either from undifferentiated cells that mature during tumor development or from progenitors committed to different lineages. To examine the BCR/ABL-sensitive target cells present in the marrow of mice treated with 5-fluorouracil, we used a single-step in vitro assay. These experiments revealed that both the P210 and P185 BCR/ABL proteins and the related v-abl protein induce lymphoid and myeloid colonies, colony types that mimic two of the prominent types of tumors found in the reconstitution model. The lymphoid colonies were similar to lymphoid colonies found following infection of normal bone marrow with respect to differentiation state and tumorigenicity. The cells in the myeloid colonies were differentiated and non-tumorigenic. Fluorescence-activated cell sorting revealed that most of the lymphoid and myeloid colonies arose from distinct precursors and that the lymphoid colonies arose from B-lineage-committed cells. These data suggest that most of the lymphomas observed in the reconstitution model arise from committed progenitors that are distinct from those involved in the myeloid disease.
Assuntos
Medula Óssea/patologia , Transformação Celular Neoplásica , Fluoruracila/farmacologia , Genes abl , Células-Tronco Hematopoéticas/patologia , Leucemia Mielogênica Crônica BCR-ABL Positiva/etiologia , Linfoma/etiologia , Animais , Sequência de Bases , Medula Óssea/imunologia , Medula Óssea/microbiologia , Proteínas de Fusão bcr-abl/genética , Interleucina-3/farmacologia , Antígeno de Macrófago 1/análise , Camundongos , Dados de Sequência Molecular , Fenótipo , Provírus/isolamento & purificaçãoRESUMO
The accumulation of (R)-(H-3)-3-quinuclidinyl benzilate (H-3 QNB) and (R,S)-1-azabicyclo(2.2.2)oct-3-yl (R,S)-alpha-hydroxy-(4-[I-125]iodophenyl) benzeneacetate (I-125 4- IQNB ) in heart, caudate/putamen, and cerebellum of rats was determined at intervals from 15 min to 4 hr after injection. The behavior of the two radiotracers in the heart is consistent with in vitro results with respect to affinities and specificities. In the brain, however, the compounds differ in tissue selectivity. At high specific activity, neither compound provides localization that is consistent with the concentration of receptor in the tissues. The results of this study do not indicate quantification of receptor concentration by means of single external images.
Assuntos
Radioisótopos do Iodo , Quinuclidinas/metabolismo , Quinuclidinil Benzilato/metabolismo , Trítio , Animais , Artérias Carótidas , Núcleo Caudado/diagnóstico por imagem , Cerebelo/diagnóstico por imagem , Feminino , Coração/diagnóstico por imagem , Técnicas In Vitro , Putamen/diagnóstico por imagem , Quinuclidinas/administração & dosagem , Quinuclidinil Benzilato/administração & dosagem , Cintilografia , Ratos , Ratos Endogâmicos , Receptores Colinérgicos/análise , Fatores de Tempo , Distribuição TecidualRESUMO
The affinities of atropine, scopolamine, 3-quinuclidinyl benzilate and twelve analogues of 3-quinuclidinyl benzilate were determined for the muscarinic acetylcholine receptor (m-AChR) using membrane preparations from caudate/putamen. The affinity constants thus obtained were compared with affinities previously reported for the m-AChR obtained from ventricular muscle. The affinities differed significantly for six of the compounds, the largest difference being 16-fold. Neither solubilization nor variation of physiologically significant salts led to a significant change in the affinity of that compound. These results are interpreted as supporting the subclassification of the muscarinic acetylcholine receptor.